Nishi J, Arimura K, Utsunomiya A, Yonezawa S, Kawakami K, Maeno N, Ijichi O, Ikarimoto N, Nakata M, Kitajima I, Fukushige T, Takamatsu H, Miyata K, Maruyama I
Department of Paediatrics, Faculty of Medicine, Kagoshima University, Japan.
Br J Haematol. 1999 Mar;104(3):482-5. doi: 10.1046/j.1365-2141.1999.01208.x.
To evaluate the possible involvement of vascular endothelial growth factor (VEGF) in the pathogenesis of Castleman's disease, we studied VEGF levels in sera and supernatants of cultured lymph nodes from two patients with the plasma cell type of Castleman's disease, and analysed the expression of VEGF immunohistochemically in the lymph nodes. Clinically, one patient was classified as the localized type and the other as the multicentric type. Histologically, mature plasma cells and hyalinized vessels were prominent in the interfollicular region. The VEGF levels of the sera and the supernatants of cultured lymph nodes of both patients were higher than those of normal controls. VEGF was strongly expressed in plasma cells in the interfollicular region of the lymph nodes of both patients, but rarely in normal lymph nodes. Our results suggest that VEGF may be involved in the marked vascular proliferation in the interfollicular region of the lymph nodes of the plasma cell type of Castleman's disease.
为评估血管内皮生长因子(VEGF)在Castleman病发病机制中的可能作用,我们研究了两名浆细胞型Castleman病患者血清及培养淋巴结上清液中的VEGF水平,并对淋巴结中VEGF进行了免疫组化表达分析。临床上,一名患者为局限型,另一名为多中心型。组织学上,成熟浆细胞和玻璃样变血管在滤泡间区域较为突出。两名患者血清及培养淋巴结上清液中的VEGF水平均高于正常对照。VEGF在两名患者淋巴结滤泡间区域的浆细胞中强烈表达,但在正常淋巴结中很少表达。我们的结果提示,VEGF可能参与了浆细胞型Castleman病患者淋巴结滤泡间区域显著的血管增生。